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ABSTRACT
Introduction: To determine the etiology of intractable convulsion, the outcome of intractable convulsions 
in pediatric patients and risk factors related to poor outcome.
Material  and  methods: This case-control study conducted on 100 children where 50 patients who fulfilled 
the criteria for intractability admitted into pediatric intensive care unit (PICU) and 50 epileptic children on 
appropriately chosen antiepileptic drug (AED) with no seizures for more than 1 year who attending to 
the pediatric neurology clinic for follow up. Full history taking, examination, investigations performed for 
patients groups on admission and then followed up to six months for an outcome. 
Results: This study showed no significant difference between studied groups as regard age, sex, consan-
guinity and positive family history but noticed a highly statistically significant increase in prenatal problems 
(n; 20 patients), neonatal seizure (n; 15 patients), and postnatal problem (n; 10 patients) in intractable 
groups compared to controlled groups (p value 0.001).Delayed developmental history (n; 40 patients) was 
significantly higher among intractable groups compared to controlled groups (p value 0.001).Intractable 
groups had significantly increased in abnormal neurological examination than controlled groups (p value 
0.001).History of prenatal problems, neonatal seizures, delayed developmental milestones, presence of 
underlying etiology of seizures, and abnormality findings in EEG and neuroimaging are risk factors for the 
intractability of convulsion. There was a significant relation between poor outcome and other studied vari-
ables including being female, presence of consanguinity, delayed developmental milestones, disturbed level 
of consciousness and secondary etiology of seizures (p value; 0.04, 0.003, 0.001, 0.001 0.001 respectively).
Conclusion: The most common etiology of intractability in epileptic children is a secondary etiology of 
seizures. Early detection of risk factors for intractable epilepsy is important to decrease intractability com-
plications. Proper perinatal care is important for decreasing prevalence of intractable epilepsy. 
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Introduction 
Convulsion is the most common neurological dis-
eases in pediatric patients and account one time in 
4–10% of children in the first 16 years of life [1]. Convul-
sion defined as a paroxysmal and transient occurrence 
of signs or symptoms resulting from abnormal neuronal 
activity originated in the brain [2].
Epilepsy is chronic brain diseases diagnosed by 
recurrent spontaneous convulsions, which start in the 
childhood period. Refractory and repeated convulsions 
can cause long-term cognitive impairment, lower of 
social participation and decreased quality of life. About 
30% of patients with epilepsy; the convulsions are in-
tractable, 70% of these patients become controlled with 
antiepileptic drugs [3].
Intractable convulsion is a life-threatening medical 
emergency that needs urgent recognition and emer-
gency treatment to decrease morbidity and mortality. 
The predictors of the intractability of convulsions are the 
presence of a structural lesion, abnormal neurological 
state and early onset of convulsion [4].
The intractable convulsion diagnosed as a failure 
of adequate two or more tolerated, suitable chosen 
anticonvulsant drug schedules whether as monother-
apies or in combination to achieve optimum freedom 
from convulsion [5].
The patients considered as intractable when 
they developed at least one convulsion or more per 
month in a 6-month period although being treated 
with at least 2 appropriately chosen antiepileptic 
drugs [6].
Corresponding author: 
Nagwan Yossery Saleh 
Pediatrics, Faculty of Medicine,  
Menoufia University Hospital, Egypt 
e-mail: drnagwan80@gmail.com
62
MEDICAL RESEARCH JOURNAL 2020. vol. 5. no. 2
www.journals.viamedica.pl/medical_research_journal
The aim of this study was to detect the etiology, 
risk factors related to intractability and poor outcome 
of convulsion in children. 
Material and methods
The study was performed from September 2016 to 
July 2018 and was approved by the local Ethical Com-
mittee. A written informed consent for each child was 
obtained from their parents prior to inclusion. In this 
case-control study, 100 children enrolled in the study 
aged 12 months to 12 years old, where epileptic children 
were selected from PICU and outpatient clinic from the 
Pediatric Neurology Unit, Pediatric Department, Menou-
fia University Hospitals. These children were divided 
into two main groups, which included: Group I included 
50 epileptic children who fulfilling the criteria for intracta-
bility, they were 18 males (36%) and 32 females (64%). 
Group II included 50 epileptic children on AEDs with 
no seizures for more than 1 year, they were 22 males 
(44%) and 28 females (56%). They underwent full history 
taking, clinical examinations and investigation. 
Inclusion criteria in the study if patient involves 
any of the following; 1) Epileptic children with intracta-
bility (failure of 2 or more first-line antiepileptic drugs to 
control seizures in children who had 1 or more seizures 
per month for 2 years). 2) Age from 2 to below 18 years.
Exclusion criteria including one of these; Patients 
with single unprovoked seizures, Patients with provoked 
seizures, Patients with poor compliance regarding 
regular drug intake or appearance of drug side effects, 
Patients with unsuitable drug choice, and Patients with 
an inborn error of metabolism.
All patients subjected to full history taking including; 
age, sex, residence, consanguinity, family history of 
epilepsy, prenatal insult, neonatal seizure and develop-
mental history. Clinical examination including; general 
examination (HR, RR, Temp, and B.P), anthropometric 
measurements in form of Wt. in kg, Ht. in cm, head 
circumference in cm, and body mass index and as-
sessment of developmental milestones and examine 
neurological reflexes.
For all patients; laboratory investigations withdrawn 
including complete blood count (CBC), serum electro-
lytes (Na, K, and Ca), Neuroimaging study including CT, 
MRI and EEG .Eventually, All patients were followed up 
for 6 months after discharge from the Pediatric Intensive 
Care Unit(PICU) .
Assessment of developmental milestones
Developmental milestones assessed according to 
the age of achievement of these milestones. To assess 
the onset of key developmental milestones without 
having to complete an entire standardized assessment, 
urgent milestones from motor and language domains 
chosen. All questions took the format: ‘At what age did 
he/she first...’ and in this study, we use data from one 
‘early’ and one ‘late’ milestone, e.g., ‘Sit without sup-
port’ and ‘Walk independently’ (gross motor), ‘Pick up 
a small object with a pincer grip, i.e., with thumb and 
forefinger’ and ‘Stack at least three small blocks or 
other small objects; stack must not fall’(fine motor), ‘Say 
their first word’ and ‘Put two or more words together’ 
(language) [7].
Delayed milestone, also called  developmental 
delays, considered when a child does not reach one of 
these stages at the expected age. But, in most cases, 
a wide variety of ages can be considered normal, and 
not a cause for medical concern. Milestones are often 
measured using percentiles, and for many milestones, 
a value between the 5th and 95th percentile does not 
require intervention, though values towards the edges 
of that range can be associated with other medical 
conditions. It is not possible to treat. The measurement 
of posture sway may be an early indicator [8].
Statistical analysis
Data were collected, tabulated, statistically analyzed 
using a personal computer with Statistical Package of 
Social Science (SPSS) (version 20; Inc., Chicago .IL) 
where the following statistics were applied. Two types of 
statistics were done: Descriptive statistics e.g. Number 
(No), percentage (%), mean (X¯) and standard deviation 
(SD). The second was Analytic statistics: Chi-squared test 
(c2), student t-test(t), Kruskal Waills test (K),one-way Anova 
test (F), Mann-Whiteny test (U), P-value ≤ 0.05 to be statis-
tically significant, P-value ≤ 0.001 to be highly statistically 
significant. Values were expressed as means and standard 
deviations or counts and percentages as appropriate.
Results
The socio-demographic data of studied groups 
showed no statistically significant difference between 
studied groups as regard age, sex, consanguinity and 
positive family history but showed a highly statistically 
significant increase in prenatal insult and postnatal 
problem in intractable groups compared to controlled 
groups (p = 0. 001). Delayed developmental history was 
significantly higher among intractable groups compared 
to controlled groups (p = 0. 001). Neonatal seizure in 
the form of partial seizures, myoclonic seizures and 
infantile spasms were more frequent in children with 
intractable convulsion (Tab. 1). 
Neurological examination of studied groups showed 
a highly significant increase in neurological abnormality 
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Table 1. Socio-demographic data of all studied patients
 Demographic data Group I Group II X2
p value
Age in years
Range 
Mean ± SD
1–12 
4.1 ± 4.2
3–12 
4.5±3.8
0.74 0.45
Sex No % No %
2.3 0.59Male 
Female 
18
32
36
64
22
28
44
56
Consanguinity No % No %
2.4 0.48Positive
Negative
21
29
42
58
15
35
30
70
Family history of epilepsy No % No %
6.9 0.067Positive
Negative
26
24
52
48
20
30
40
60
Prenatal problems No % No % 36.1
0.001*NO insult
Kernicterus
Cyanosis
Obstructed labor with HIE
30
5
5
10
60
10
10
20
37
3
5
5
74
6
10
10
Neonatal seizure No % No %
28.7
0.001*
 Positive
 Negative
15
35
30
70
9
41
18
82
Postnatal problem No % No % 28.8
0.001* Positive
 Negative
10
40
20
80
8
42
16
84
Developmental history No % No % 74.2
0.001*Normal
Delayed
Lost after being acquired
10
30
10
20
60
20
25
25
0
50
50
0
 X2 — Chi square test; *statistically significant p ≤ 0.05; HIE — Hypoxic Ischemic Encephalopathy; Group I — intractable epileptic patients; Group 
II — controlled epileptic patients
in intractable groups than controlled groups regarding 
mentality, speech, cranial nerve and motor system 
assessment (p = 0.001) (Tab. 2).
Also, this study noticed a highly significant difference 
between the two studied groups; intractable epileptic 
group and controlled epileptic group, regarding the 
number of antiepileptic drugs taken to control convul-
sions (p = 0.001) (Tab. 3).
History of prenatal problems, neonatal seizures, de-
layed developmental milestones, presence of underlying 
etiology of seizures, abnormality in Electro Encephalo-
grams (EEG) and Neuroimaging studies are risk factors 
for the intractability of convulsion (p = 0.001) (Tab. 4).
As regarding the etiology of seizures, there was 
a significant increase in secondary causes in intractable 
groups than controlled groups (p = 0.001) (Tab. 5). 
There was a significant relation between poor 
outcome and other studied variables including being 
female, presence of consanguinity, delayed develop-
mental milestones and disturbed level of consciousness 
and secondary etiology of seizures (Tab. 6).
Discussion
Intractable convulsions in children are a life-threat-
ening disease with serious risk of neurological insults 
which considered a medical emergency [9]. Epilepsy 
accounts for more than 50% of children, and refractory 
epilepsy is a big problem in this age group [10].
Only 3% of children fail to respond to the first two 
anticonvulsants drugs become seizure-free by using 
a third anticonvulsant drug, while the convulsions be-
come intractable in about one-third of these children [11].
In our study, there was highly statistically signifi-
cant difference between the two groups as regarding 
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 Table 2. Neurological examination of studied patients
Neurological examination Group I Group II X2 p value
Mentality N % N %
38.2 0.001*
•	 Normal 
•	 Low
18
32
36
64
35
15
70
30
Speech N % N % 36.2 0.001*
•	 Normal 
•	 Delayed 
•	 Couldn’t be assessed
15
33
2
30
66
4
35
15
0
70
30
0
Cranial nerve N % N %
40.7 0.001*
•	 Normal
•	 Affected
33
17
66
34
40
10
80
20
Motor system N % N %
84.0 0.001*A. Power
•	 Normal 
•	 Weakness 
25
25
50
50
25
25
50
50
B. Tone 
•	 Normal tone 
•	 Hypotonia
•	 Hypertonia
25
13
12
50
26
24
38
5
7
76
10
14
34.0 0.001*
 X2 — Chi square test; *Statistically significant p ≤ 0.05
Table 3. Response of studied groups to anti-epileptic drugs
Drug therapy Group I Group II Test p value
N % N %
86.2 0.001*Monotherapy control 0 0 30 60
Ditherapy control 0 0 20 40 66.8 0.005*
Polytherapy control 43 86 0 0 74.9 0.002*
Uncontrolled drug therapy 7 14 0 0 89.4 0.001*
X2 — Chi-square test; *Statistically significant p ≤ 0.05
mentality, speech and motor system affection and also; 
Tripathi et al. [12] and Saygiet al. [13] found that there 
was an underlying etiology that affects the brain and 
motor system.
Our results revealed that there was a significant 
statistical difference between studied groups regard-
ing response to drugs (monotherapy, polytherapy), 
where all patients with intractable convulsions needed 
polytherapy. This agreed with Smith et al. [14] as 
the definition of intractability depend on failure of 
treatment with two (or more) tolerated, appropriately 
chosen and used antiepileptic drug schedules (wheth-
er as one drug therapy or in combination) to achieve 
sustained seizure free [5]. Presence of underlying 
neurologic deficit points to either the intrinsic severity 
of epilepsy or to the severity of underlying etiology. 
These two factors may account for pharmacy resis-
tance noticed by Patil et al. [15].
We found that there was a significant difference 
between studied groups regarding etiology where the 
secondary type of epilepsy (66%) was more with intrac-
table epileptic patients due to cerebral palsy (45.5%) and 
post-traumatic intracranial hemorrhage (18.2%). Kwan, et 
al. [16], Berg et al. [17] and Ohtsuka et al. [18] found that 
symptomatic epilepsy associated with intractability. In the 
study of Manoj et al. [19]; 71 % of intractable epileptic 
children had remote symptomatic etiology, perinatal 
asphyxia constituted almost 50% children of intractable 
seizures and was an important predictor for intractability. 
In the study of Moinuddin et al. [20]; hypoxic-ischemic 
damage of the brain due to perinatal asphyxia and cere-
bral palsy were the main causes of symptomatic epilepsy.
We found that the presence of the history of pre-
natal problem, delayed developmental milestones, the 
secondary type of epilepsy, and neuroimaging studies 
abnormalities were risk factors for epilepsy intractability. 
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Table 4. Risk factors of intractable convulsion in all studied groups
Risk factors Group I
 N = 50
Group II
N = 50
X2 p value
Sex
Male
Female
N % N % 0.66 0.041
18
32
36
64
22
28
44
56
History of prenatal problems N % N % 0.8 0.001*
20 40 13 26
Presence of consanguinity 21 42 15 30 1.5 0.21
Family history of convulsion or neurological disorder 26 52 20 40 1.2 0.02*
Abnormal developmental milestones 40 80 25 50 9.8 0.001*
History of neonatal seizures 15 30 9 18 9.1 0.002*
Presence of postnatal problem 10 20 8 16 0.27 0.60
Partial type of seizure or partial with secondary generalization 13 26 4 8 5.7 0.01*
Underlying etiology of seizures 33 66 25 50 2.6 0.001*
Abnormal EEG finding 39 78% 29 58% 4.5 0.03*
Abnormal neuroimaging studies 22 44% 10 20% 6.9 0.001*
*Statistically significant p ≤ 0.05
Table 5. The most probable etiology of seizures among all studied patients
Etiology of epilepsy Group I Group II X2 p value 
Idiopathic
N % N %
66.1 0.001*17 34 25 50
Secondary 33 66 25 50 66.1 0.001*
Cerebral palsy 15 45.5 20 80 12.56 0.002*
Neurodegenerative 4 12.1 0 0 -
Congenital Malformation 5 15.1 0 0 3.184 FEp = 0.235
*Post neuro-infection sequalae 2 6.1 3 12 0.85 0.12
Post traumatic intracranial hemorrhage 6 18.2 2 8 0.64 0.012*
Abscess 1 3 0 0 - -
X2 — Chi-square test; FE × Fisher Exact test; *statistically significant ≤0.05; *Post-neuro-infection — post meningitic, post-encephalitic
History of neonatal seizures associated with intrac-
tability risk caused by neuronal damage; during this 
period rapid brain development occur; so, most of these 
children demonstrate a history of prenatal asphyxia, 
congenital malformations and other factors that play 
an important role in the development of intractable 
epilepsy .accordingly type of neonatal seizures; partial 
seizures, myoclonic seizures and infantile spasms were 
more frequent in children with intractable convulsion 
and this agrees with the result of Joseph et al. [21]. 
Eriksson and Koivikko [22] stated that the presence of 
mixed seizure types, myoclonic seizures and infantile 
spasms may cause poor seizure control15. In the study 
of Chawla et al. [23], there was an association between 
myoclonic seizures and intractability.
There were significant relations between delayed 
developmental milestones, decreased conscious level, 
and etiology of convulsions, electrolyte disturbance 
and poor outcome of patients. Camfield et al. [24] and 
Berg et al. [25] found that the underlying diagnosis was 
the major predictor of mortality and outcome. And also 
Shinnar [26] found that an underlying congenital cause 
or early childhood brain damage causing neurodeficits is 
a strong predictor for a poor long-term seizure outcome.
Conclusions
Intractable Convulsion results from primary central 
nervous system insult or systemic disease with sec-
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Table 6. Relation between outcome with Socio-demographic data, clinical and etiology of intractable epileptic group
Socio-demographic data Outcome for patient 
with intractable convulsion
X2 p value
Poor Good
Sex 
Male N = 18
Female N = 32
No % N %
3.6 0.048
23
16
46
10
9
20
18
History of prenatal problems N = 13 9 18 4 8 0.3 0.8
Presence of consanguinity N = 21 8 16 13 26 8.7 0.003*
Family history of convulsion or neurological disorder N = 26 17 34 9 18 0.2 0.6
Abnormal developmental milestones N = 40 31 62 8 16 19.3 0.001*
Seizure type
•	 Generalized N = 37
•	 Partial N = 13
21
10
42
20
16
3
32
6
1.6 0.19
Conscious level
•	 Conscious N = 24
•	 Disturbed N = 26
5
26
10
52
19
-
38 29.3 0.001*
Associated electrolyte disturbance
•	 Na N = 12
•	 K N = 12
•	 Ca N = 19
2
1
12
4
2
24
10
11
7
20
22
14
12.1 0.002*
Etiology
Idiopathic N = 17
Secondary N = 33
0
31
0
62
17
2
34
4
28.0 0.001*
X2 — Chi-square test; *Statistically significant p ≤ 0.05
ondary central effect. The poor outcome associated 
with females more than males, in patients with a posi-
tive family history of epilepsy, delayed developmental 
milestones, patients with a disturbed conscious level 
and patients with secondary epilepsy.
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